Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 pilot study of oral ladarixin in active bullous pemphigoid
2011-000756-42Phase 2Terminated
- Sponsor
- Dompé
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ladarixin in Bullous Pemphigoid (BP), sponsored by Dompé. Primary endpoints: Total number of blisters, Modified ABSIS score and 6 more. Started Jun 2011; status: terminated.
02
Drugs
ladarixin
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on 2011-000756-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000756-42.